During the past decade, Sound Healthcare conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sound Healthcare" are "Diabetes Mellitus, Type 2" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Sound Healthcare" in a lesser frequency.

Most popular intervention types in "Sound Healthcare" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin (oral)" (1 trials), "Glimepiride (oral)" (1 trials), "ITCA 650 (exenatide in DUROS)" (1 trials) and "ITCA 650 20/60 mcg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sound Healthcare" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sound Healthcare". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sound Healthcare, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sound Healthcare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".